Genzyme Transgenics Corporation
Records under this name other than patents Genzyme Transgenics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Genzyme Transgenics Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,441,145 | Transgenically produced Antithrombin III Formerly held Term ended Ended no later than Aug 14, 2018 · USPTO record | Term ended | Ended no later than Aug 14, 2018 | USPTO record |
| US 6,528,699 | Transgenically produced non-secreted proteins Formerly held Term ended Term ended Feb 24, 2018 · USPTO record | Term ended | Term ended Feb 24, 2018 | USPTO record |
| US 7,928,064 | Transgenically Produced Antithrombin III Formerly held Term ended Ended no later than Dec 9, 2016 · Low confidence | Term ended | Ended no later than Dec 9, 2016 | Low confidence |
| US 6,268,487 | Purification of biologically active peptides from milk Formerly held Term ended Term ended May 13, 2016 · USPTO record | Term ended | Term ended May 13, 2016 | USPTO record |
| US 7,019,193 | Treatments using transgenic goat produced antithrombin III Formerly held Term ended Term ended Oct 17, 2015 · USPTO record | Term ended | Term ended Oct 17, 2015 | USPTO record |
| US 7,101,971 | Erythropoietin Analog-Human Serum Albumin Fusion Formerly held Lapsed on the fee record Ended Sep 5, 2014 · Low confidence | Lapsed on the fee record | Ended Sep 5, 2014 | Low confidence |
| US 7,632,980 | Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems Formerly held Lapsed on the fee record Ended Dec 15, 2013 · USPTO record | Lapsed on the fee record | Ended Dec 15, 2013 | USPTO record |
| US 7,501,553 | Non-Human Transgenic Mammal Comprising a Modified MSP-1 Nucleic Acid Formerly held Lapsed on the fee record Ended Mar 10, 2013 · Low confidence | Lapsed on the fee record | Ended Mar 10, 2013 | Low confidence |
| US 7,354,594 | Merozoite Surface Protein 1 Lacking Glycosylation Sites Formerly held Lapsed on the fee record Ended Apr 8, 2012 · Medium confidence | Lapsed on the fee record | Ended Apr 8, 2012 | Medium confidence |
| US 6,593,463 | Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems Formerly held Lapsed on the fee record Ended Jul 15, 2011 · USPTO record | Lapsed on the fee record | Ended Jul 15, 2011 | USPTO record |